艾伯維公司 ABBV 深 滬
等待開盤 07-29 09:30:00 美东时间
188.52
-1.760
-0.92%
華盛通- 最 高191.21
- 今 開191.21
- 成交量 377.67万股
- 最 低 187.64
- 昨 收 190.28
- 總市值 3329.26亿
- 52周最高 215.38
- 市盈率 靜 78.87
- 換手率 0.21%
- 52周最低 158.89
- 委 比 -99.50%
- 總股本 17.66亿
- 歷史最高 215.38
- 量 比 0.90
- 振 幅 1.88%
- 歷史最低 -15.66
- 每 手 1
- 風險率 11.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多苹果、微软、亚马逊、Meta财报来袭
作者丨Oliver Rodzianko 编译 | 华尔街大事件 本周科技巨头、能源巨头、金融公司、医疗保健行业领袖和消费者品牌将陆续发布大量财报。 焦点将集中...
07-28 20:40
AbbVie’s Lutikizumab Study: A Potential Game-Changer for Hidradenitis Suppurativa
Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing ...
07-25 00:27
AbbVie Advances Pediatric Migraine Study with Atogepant
Abbvie (($ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing ...
07-25 00:20
BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology
BioVie Inc. presented research on Bezisterim, a drug candidate modulating inflammation and insulin sensitivity, at the World Conference on Aging and Gerentology (WCAG-2025). The study showed that Bezisterim significantly decelerated biological aging in Alzheimer’s Disease patients, reducing age acceleration by up to 4.24 years on certain clocks. It also decreased inflammatory cytokines like TNFα, IL-6, and IL-17, and improved metabolic biomarkers...
07-24 12:00
BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project
Select Business Owners Will Receive Access to Coaching, Mentorship, and Community During Exclusive 12-Week Virtual "Boostcamp" Additionally, 20 Entrepreneurs Will Each Receive a $20,000 Gran...
07-22 20:00
艾伯维ABBV - 932启动Ⅰ期临床 适应症为健康受试者
药物临床试验登记与信息公示平台数据显示，艾伯维医药贸易（上海）有限公司的一项在中国健康成人受试者中评价ABBV - 932的药代动力学、安全性和耐受性的多次给药...
07-22 18:30
美股还能再牛多久？顶流策略师与最新数据深度解读下半年行情
近期，美股再次演绎出了“牛气冲天”，科技、软件、人工智能创新板块屡创新高。许多散户和机构投资者都在追问：市场高处不胜寒，是否到了该落袋为安的时刻？美股投资网将结...
07-21 20:33
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn ...
07-21 19:46
大摩重申艾伯维(ABBV.US)买入评级：低波动+业绩双支撑，目标价250美元
艾伯维公司近日获得摩根士丹利分析师Terrence Flynn的持续看好，并重申对这家制药巨头的"买入"评级，并维持250美元的目标价。
07-21 10:48
My Top 2 Earnings Picks For This Earnings Season
This morning, I woke up to the sound of pounding rain on the roof of my bus and...
07-17 04:05
